MIR31HG and pancreatic ductal adenocarcinoma: MIR31HG was found to be remarkably upregulated in tumor tissues of esophageal squamous cell carcinoma, pancreatic ductal adenocarcinoma, breast cancer, and basal subtype of bladder cancer, serving as a bona fide diagnostic indicator [10, 31–33].